A Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population
Authors
Bagwell, SageLavitas, Pavel
Pomfret, Thomas C.
Greenwood, Bonnie C.
Trask, Nicole M.
Tran, Stephanie
Schiff, Nancy L.
Hydery, Tasmina
Leto, Patricia
Price, Mylissa K.
Alper, Caroline J.
Lenz, Kimberly J.
Jeffrey, Paul L.
UMass Chan Affiliations
Commonwealth Medicine, Office of Clinical Affairs/MassHealthCommonwealth Medicine, Clinical Pharmacy Services
Commonwealth Medicine, Center for Health Policy and Research
Document Type
PosterPublication Date
2018-04-25Keywords
MedicaidPharmacy
Drug Utilization Review
Health Economics
Health Policy
Health Services Administration
Health Services Research
Pharmaceutical Preparations
Pharmacoeconomics and Pharmaceutical Economics
Metadata
Show full item recordAbstract
This poster evaluates the financial impact of high-cost infused medications across three site of care programs. Site of care programs help payers save money on specialty drug spend by shifting utilization on high costs infused medications to less costly sites of administration. The objective of this project was to evaluate the costs associated with the administration of select high-cost infused medications in site of care programs in Massachusetts Medicaid populations. Research was done through retrospective analysis that included pharmacy and medical claims data for select high cost infused medications between April 1, 2017 - September 20, 2017. This presentation was given at the 2018 Managed Care & Specialty Pharmacy Annual Meeting and received the AMCP Foundation Best Poster Award in the Resident and Fellows category.DOI
10.13028/kx5p-ak35Permanent Link to this Item
http://hdl.handle.net/20.500.14038/26958Rights
© 2018 University of Massachusetts Medical Schoolae974a485f413a2113503eed53cd6c53
10.13028/kx5p-ak35